Your browser doesn't support javascript.
loading
Role of lipid droplets in neurodegenerative diseases: From pathogenesis to therapeutics.
Kang, Yubing; Yeap, Yee Jie; Yang, Jing; Ma, Sufang; Lim, Kah Leong; Zhang, Qin; Lu, Li; Zhang, Chengwu.
Afiliação
  • Kang Y; School of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030000, China.
  • Yeap YJ; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.
  • Yang J; School of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030000, China.
  • Ma S; School of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030000, China.
  • Lim KL; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.
  • Zhang Q; Yuncheng Central Hospital, Yuncheng 044020, China. Electronic address: Zhangqin19762@126.com.
  • Lu L; School of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030000, China; Shanxi Engineering Research Center for Precisive Diagnosis and Treatment of Neurodegenerative Diseases, Jinzhong 030600, China. Electronic address: luli@sxmu.edu.cn.
  • Zhang C; School of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030000, China; Shanxi Engineering Research Center for Precisive Diagnosis and Treatment of Neurodegenerative Diseases, Jinzhong 030600, China. Electronic address: chengwu_zhang@sxmu.edu.cn.
Neurosci Biobehav Rev ; 165: 105867, 2024 Oct.
Article em En | MEDLINE | ID: mdl-39208878
ABSTRACT
Neurodegenerative diseases (NDDs) are a series of disorders characterized by the progressive loss of specific neurons, leading to cognitive and locomotor impairment. NDDs affect millions of patients worldwide but lack effective treatments. Dysregulation of lipids, particularly the accumulation of lipid droplets (LDs), is strongly implicated in the pathogenesis of NDDs. How LDs contribute to the occurrence and development of NDDs, and their potential as therapeutic targets remain to be addressed. In present review, we first introduce the processes of LDs formation, transportation and degradation. We then highlight how the accumulation of LDs contributes to the pathogenesis of NDDs in a cell type-specific manner. Moreover, we discuss currently available methods for detecting LDs and elaborate on LDs-based therapeutic strategies for NDDs. Lastly, we identify gaps that need to be filled to better leverage LD-based theranostics in NDDs and other diseases. We hope this review could shed light on the role of LDs in NDDs and facilitate the development of novel therapeutic strategies for NDDs.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Gotículas Lipídicas Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Gotículas Lipídicas Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article